The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index, and 1 are not checked yet.
Cross-national epidemiology of DSM-IV major depressive episode
Open accessAbstract
BACKGROUND: Major depression is one of the leading causes of disability worldwide, yet epidemiologic data are not available for many countries, particularly low- to middle-income countries. In this paper, we present data on the prevalence, impairment and demographic correlates of depression from 18 high and low- to middle-income countries in the World Mental Health Survey Initiative. METHODS: Major depressive episodes (MDE) as defined by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DMS-IV) were evaluated in face-to-face interviews using the World Health Organization Composite International Diagnostic Interview (CIDI). Data from 18 countries were analyzed in this report (n = 89,037). All countries surveyed representative, population-based samples of adults. RESULTS: The average lifetime and 12-month prevalence estimates of DSM-IV MDE were 14.6% and 5.5% in the ten high-income and 11.1% and 5.9% in the eight low- to middle-income countries. The average age of onset ascertained retrospectively was 25.7 in the high-income and 24.0 in low- to middle-income countries. Functional impairment was associated with recency of MDE. The female: male ratio was about 2:1. In high-income countries, younger age was associated with higher 12-month prevalence; by contrast, in several low- to middle-income countries, older age was associated with greater likelihood of MDE. The strongest demographic correlate in high-income countries was being separated from a partner, and in low- to middle-income countries, was being divorced or widowed. CONCLUSIONS: MDE is a significant public-health concern across all regions of the world and is strongly linked to social conditions. Future research is needed to investigate the combination of demographic risk factors that are most strongly associated with MDE in the specific countries included in the WMH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lifetime MDD prevalence is typically about threefold higher than the 12-month prevalence, indicating that MDD affects 1 out of every 6 adults at some point in their life 3,18,19”
From Major depressive disorder (2016) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“affects in a specific year about 6% of the adult population worldwide 3”
From Major depressive disorder (2016) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although considerable variation in inter-country prevalence is noted, the overall estimates in high-income countries (5.5%) and low- and middle-income countries (LMICs; 5.9%) are not different. Data derived from the World Mental Health Survey 3 .”
From Major depressive disorder (2016) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A study including 18 countries from the WHO World Mental Health Surveys (Kessler & Usten, 2008) reported that the relationship between gender and MDE did not differ significantly between high-income and low- to middle-income countries”
From Gender Differences in Depression in Representative National Samples: Meta-Analyses of Diagnoses and Symptoms (2017) · cites this paper as Bromet et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“However, findings also suggest that the 2:1 ratio is not universal and may vary substantially across nations.”
From Gender Differences in Depression in Representative National Samples: Meta-Analyses of Diagnoses and Symptoms (2017) · cites this paper as Bromet et al., 2011
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · Cited by 6,884
Robins, L. N. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780290015001 · Cited by 5,219
Kessler, R. C., & Üstün, T. B. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.168 · Cited by 4,771
Self-citationDepression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070
(2004) · JAMA · doi:10.1001/jama.291.21.2581 · Cited by 3,448 · cited 1×
“Details about WMH survey methods and weighting procedures are presented elsewhere [11,17].”
Ellis, P. D. (2010) · doi:10.1017/cbo9780511761676 · Cited by 2,461
Cross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302
Evidence-based health policy—lessons from the Global Burden of Disease Study
Murray, C. J. L., & Lopez, A. D. (1996) · Science · doi:10.1126/science.274.5288.740 · Cited by 2,178
Income inequality and population health: A review and explanation of the evidence
Wilkinson, R. G., & Pickett, K. E. (2006) · Social Science & Medicine · doi:10.1016/j.socscimed.2005.08.036 · Cited by 1,780
Global burden of depressive disorders in the year 2000
Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. L. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.5.386 · Cited by 1,735 · cited 2×
“Major depression is a serious, recurrent disorder linked to diminished role functioning and quality of life, medical morbidity, and mortality [1,2].”
BackgroundResult
Research works printed but not linked: 1
- Research Triangle Institute: SUDAAN: Professional Software for Survey Data Analysis [computer program]. 2002, Research Triangle Park, NC: Research Triangle Institute, 8.0.1
Cited by
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
The Epidemiology of Depression Across Cultures
Kessler, R. C., & Bromet, E. J. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114409 · Cited by 2,657
Self-citationSalk, R. H., Hyde, J. S., & Abramson, L. Y. (2017) · Psychological Bulletin · doi:10.1037/bul0000102 · Cited by 2,622
“Study d Country NM NF Measure Year Age Sample E F Aalto et al. (2012)a .27 Finland 326 371 BDI 2001 30–34 Health 2000 2 Aalto et al. (2012)a .29 Finland 353 388 BDI 2001 35–39 Health 2000 2 Aalto et al. (2012)a .14 Finland 341 381 BDI 2001 40–44 Health 2000 2 Aalto et al. (2012)a .10 Finland 379 435 BDI 2001 45–49 Hea…”
InfluentialOtte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4602 · Cited by 1,737
Metadata
- Authors
- Bromet, E., Andrade, L. H., Hwang, I., Sampson, N. A., Alonso, J., de Girolamo, G., de Graaf, R., Demyttenaere, K., Hu, C., Iwata, N., Karam, A. N., Kaur, J., Kostyuchenko, S., Lépine, J.-P., Levinson, D., Matschinger, H., Mora, M. E. M., Browne, M. O., Posada-Villa, J., Viana, M. C., Williams, D. R., & Kessler, R. C.
- Affiliations
- State University of New York (US)
- Universidade de São Paulo (BR)
- Harvard University (US)
- Municipal Institute for Medical Research (ES)
- Universitair Ziekenhuis Leuven (BE)
- Shenzhen KangNing Hospital (CN)
- Hiroshima International University (JP)
- Inserm (FR)
- Israel Ministry of Health (IL)
- Leipzig University (DE)
- Corresponding author
- Bromet, Evelyn
- ORCID
- Venue
- BMC Medicine
- Published
- 2011-07-26
- Volume
- 9
- Issue
- 1
- Pages
- 90-90
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC3163615
- OpenAlex
- W2162510673
- Cited by
- 2,221
- References
- 38
- Citations by year
- 2026: 75 · 2025: 133 · 2024: 168 · 2023: 188 · 2022: 225 · 2021: 215 · 2020: 198 · 2019: 138 · 2018: 115 · 2017: 167 · 2016: 147 · 2015: 142 · 2014: 126 · 2013: 111 · 2012: 56
- FWCI
- 133.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (publishedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion, cc-by)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
- Greater South Information System
- Funders
- Robert Wood Johnson Foundation (044708, Grant 044708)
- John D. and Catherine T. MacArthur Foundation (R01 DA016558, R13-MH066849)
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Sanofi
- World Health Organization
- SRA International
- Kaiser Permanente
- University of Michigan
- Janssen Scientific Affairs
- European Commission (QLG5–1999-01042, SANCO2004123, 2004123)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (03/00204-3, 03/00204?)
- Generalitat de Catalunya (01042)
- National Insurance Institute of Israel
- Ministry of Health, Labour and Welfare
- Ministerio de Ciencia y Tecnología (SAF 2000 158-CE)
- Regione Piemonte (00/0028)
- National Institutes of Health (5r13mh066849-04, 5r01mh069864-04, 5r01mh070884-05)
- Substance Abuse and Mental Health Services Administration
- Pfizer Foundation (R01‐MH069864, R01-DA016558, R13-MH066849, R03-TW006481)
- Pan American Health Organization
- Instituto de Salud Carlos III (CB06/02/0046, CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP, RETICS RD06/0011, RD06/0011, FIS 00/0028, CIBER CB06/02/0046)
- Departament de Salut, Generalitat de Catalunya
- National Institute of Mental Health (R13-MH-066849, R0 1-MH61905, R01‐MH070884, U01-MH-60220, R01MH061905, R01MH059575, MH60220, U01MH060220, R01‐MH069864)
- National Institute on Drug Abuse (R01DA016558)
- Fogarty International Center (FIRCA R03TW006481, R03TW006481)
- Cilag
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Keywords
- major depressive episode, depression prevalence, functional disability, demographic correlates, low- and middle-income countries, high-income countries, age of onset, gender differences, marital status, social conditions, cross-national comparison
- MeSH terms
- Adolescent, Adult, Aged, Depression, Developing Countries, Female, Humans, Interviews as Topic, Male, Middle Aged, Socioeconomic Factors, Global Health, Prevalence, Age Distribution, Sex Distribution, Developed Countries, Diagnostic and Statistical Manual of Mental Disorders, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cross-national epidemiology of DSM-IV major depressive episode. https://app.cochat.ai/papers/10.1186/1741-7015-9-90
- The paper
- Bromet, E., Andrade, L. H., Hwang, I., Sampson, N. A., Alonso, J., de Girolamo, G., de Graaf, R., Demyttenaere, K., Hu, C., Iwata, N., Karam, A. N., Kaur, J., Kostyuchenko, S., Lépine, J.-P., Levinson, D., Matschinger, H., Mora, M. E. M., Browne, M. O., Posada-Villa, J., . . . Kessler, R. C. (2011). Cross-national epidemiology of DSM-IV major depressive episode. BMC Medicine. https://doi.org/10.1186/1741-7015-9-90
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.